Nice View of CleanEx Exp : GSE6532B_DOC

[General] [References] [Expression data]

General information about the entry
Dataset code GSE6532B
Dataset Title Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade
Description Purpose: A number of microarray studies have reported distinct molecular profiles of breast cancers (BC): basal-like, ErbB2-like and two to three luminal-like subtypes. These were associated with different clinical outcomes. However, although the basal and the ErbB2 subtypes are repeatedly recognized, identification of estrogen receptor (ER)-positive subtypes has been inconsistent. Refinement of their molecular definition is therefore needed. Materials and methods: We have previously reported a gene-expression grade index (GGI) which defines histological grade based on gene expression profiles. Using this algorithm, we assigned ER-positive BC to either high or low genomic grade subgroups and compared these to previously reported ER-positive molecular classifications. As further validation, we classified 666 ER-positive samples into subtypes and assessed their clinical outcome. Results: Two ER-positive molecular subgroups (high and low genomic grade) could be defined using the GGI. Despite tracking a single biological pathway, these were highly comparable to the previously described luminal A and B classification and significantly correlated to the risk groups produced using the 21-gene recurrence score. The two subtypes were associated with statistically distinct clinical outcome in both systemically untreated and tamoxifen-treated populations. Conclusions: The use of genomic grade can identify two clinically distinct ER-positive molecular subtypes in a simple and highly reproducible manner across multiple datasets. This study emphasizes the important role of proliferation-related genes in predicting prognosis in ER-positive BC..
Organism Homo sapiens
Format Type Intensity
Affymetrix;HG-U133B
Number of Experiments 327
Maximum log 9.44458432975236
Minimum log -3.48935576161055
References
Original URL http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE6532
Paper Reference Loi S et al. J Clin Oncol. 2007 Apr 1;25(10):1239-46.
MEDLINE Reference 17401012
Experiments
Experiment numberExperiment CodeExperiment Description
1GSE6532B_GSM151254KIT_82A83 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX1;
2GSE6532B_GSM151247KIT_6B85 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX2;
3GSE6532B_GSM151257KIT_8B87 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX3;
4GSE6532B_GSM151226KIT_289C75 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX4;
5GSE6532B_GSM151234KIT_39C24 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX5;
6GSE6532B_GSM151179KIT_104B91 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX6;
7GSE6532B_GSM151232KIT_313A87 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX7;
8GSE6532B_GSM151238KIT_48A46 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX8;
9GSE6532B_GSM151241KIT_55A79 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX9;
10GSE6532B_GSM151231KIT_311A27 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX10;
11GSE6532B_GSM151246KIT_69A93 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX11;
12GSE6532B_GSM151237KIT_46A25 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX12;
13GSE6532B_GSM151250KIT_76A44 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX13;
14GSE6532B_GSM151249KIT_72A92 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX14;
15GSE6532B_GSM151181KIT_114B68 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX15;
16GSE6532B_GSM151185KIT_138B34 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX16;
17GSE6532B_GSM151200KIT_173B43 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX17;
18GSE6532B_GSM151207KIT_194B60 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX18;
19GSE6532B_GSM151210KIT_207C08 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX19;
20GSE6532B_GSM151183KIT_131B79 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX20;
21GSE6532B_GSM151184KIT_135B40 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX21;
22GSE6532B_GSM151186KIT_139B03 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX22;
23GSE6532B_GSM151194KIT_162B98 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX23;
24GSE6532B_GSM151220KIT_252C64 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX24;
25GSE6532B_GSM151127OXFT_2220 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX25;
26GSE6532B_GSM151126OXFT_2190 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX26;
27GSE6532B_GSM151123OXFT_2152 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX27;
28GSE6532B_GSM151128OXFT_2221 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX28;
29GSE6532B_GSM151122OXFT_209 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX29;
30GSE6532B_GSM151102OXFT_1769 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX30;
31GSE6532B_GSM151176OXFT_928 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX31;
32GSE6532B_GSM151121OXFT_2093 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX32;
33GSE6532B_GSM151103OXFT_1770 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX33;
34GSE6532B_GSM151151OXFT_630 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX34;
35GSE6532B_GSM151094OXFT_1342 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX35;
36GSE6532B_GSM151131OXFT_2340 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX36;
37GSE6532B_GSM151130OXFT_2338 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX37;
38GSE6532B_GSM151132OXFT_2341 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX38;
39GSE6532B_GSM151109OXFT_1902 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX39;
40GSE6532B_GSM151114OXFT_1982 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX40;
41GSE6532B_GSM151142OXFT_5210 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX41;
42GSE6532B_GSM151117OXFT_2027 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX42;
43GSE6532B_GSM151077OXFT_1133 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX43;
44GSE6532B_GSM151097OXFT_1441 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX44;
45GSE6532B_GSM151096OXFT_1432 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX45;
46GSE6532B_GSM151075OXFT_1125 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX46;
47GSE6532B_GSM151069OXFT_1070 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX47;
48GSE6532B_GSM151157OXFT_700 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX48;
49GSE6532B_GSM151164OXFT_742 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX49;
50GSE6532B_GSM151163OXFT_738 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX50;
51GSE6532B_GSM151153OXFT_669 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX51;
52GSE6532B_GSM151133OXFT_3597 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX52;
53GSE6532B_GSM151152OXFT_638 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX53;
54GSE6532B_GSM151125OXFT_2188 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX54;
55GSE6532B_GSM151119OXFT_2069 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX55;
56GSE6532B_GSM151149OXFT_596 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX56;
57GSE6532B_GSM151150OXFT_619 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX57;
58GSE6532B_GSM151155OXFT_680 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX58;
59GSE6532B_GSM151139OXFT_443 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX59;
60GSE6532B_GSM151120OXFT_2092 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX60;
61GSE6532B_GSM151099OXFT_1579 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX61;
62GSE6532B_GSM151140OXFT_4904 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX62;
63GSE6532B_GSM151141OXFT_511 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX63;
64GSE6532B_GSM151162OXFT_736 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX64;
65GSE6532B_GSM150875KIU_101B88 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX65;
66GSE6532B_GSM150876KIU_105B13 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX66;
67GSE6532B_GSM150877KIU_106B55 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX67;
68GSE6532B_GSM150878KIU_111B51 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX68;
69GSE6532B_GSM150879KIU_113B11 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX69;
70GSE6532B_GSM150880KIU_120B73 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX70;
71GSE6532B_GSM150881KIU_124B25 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX71;
72GSE6532B_GSM150883KIU_127B00 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX72;
73GSE6532B_GSM150884KIU_134B33 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX73;
74GSE6532B_GSM150885KIU_136B04 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX74;
75GSE6532B_GSM150886KIU_140B91 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX75;
76GSE6532B_GSM150887KIU_144B49 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX76;
77GSE6532B_GSM150888KIU_151B84 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX77;
78GSE6532B_GSM150889KIU_155B52 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX78;
79GSE6532B_GSM150890KIU_163B27 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX79;
80GSE6532B_GSM150891KIU_164B81 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX80;
81GSE6532B_GSM150892KIU_172B19 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX81;
82GSE6532B_GSM150893KIU_177B67 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX82;
83GSE6532B_GSM150894KIU_184B38 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX83;
84GSE6532B_GSM150895KIU_188B13 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX84;
85GSE6532B_GSM150896KIU_196B81 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX85;
86GSE6532B_GSM150897KIU_197B95 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX86;
87GSE6532B_GSM150898KIU_199B55 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX87;
88GSE6532B_GSM150899KIU_205B99 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX88;
89GSE6532B_GSM150902KIU_220C70 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX89;
90GSE6532B_GSM150903KIU_227C50 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX90;
91GSE6532B_GSM150904KIU_229C44 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX91;
92GSE6532B_GSM150905KIU_231C80 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX92;
93GSE6532B_GSM150906KIU_233C91 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX93;
94GSE6532B_GSM150907KIU_242C21 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX94;
95GSE6532B_GSM150908KIU_243C70 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX95;
96GSE6532B_GSM150909KIU_247C76 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX96;
97GSE6532B_GSM150910KIU_248C91 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX97;
98GSE6532B_GSM150911KIU_24C30 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX98;
99GSE6532B_GSM150912KIU_259C74 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX99;
100GSE6532B_GSM150913KIU_260C91 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX100;
101GSE6532B_GSM150914KIU_266C51 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX101;
102GSE6532B_GSM150915KIU_268C87 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX102;
103GSE6532B_GSM150916KIU_272C88 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX103;
104GSE6532B_GSM150917KIU_278C80 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX104;
105GSE6532B_GSM150918KIU_279C61 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX105;
106GSE6532B_GSM150919KIU_280C43 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX106;
107GSE6532B_GSM150920KIU_282C51 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX107;
108GSE6532B_GSM150921KIU_284C63 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX108;
109GSE6532B_GSM150922KIU_286C91 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX109;
110GSE6532B_GSM150923KIU_28C76 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX110;
111GSE6532B_GSM150924KIU_292C66 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX111;
112GSE6532B_GSM150925KIU_303C36 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX112;
113GSE6532B_GSM150926KIU_304C89 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX113;
114GSE6532B_GSM150927KIU_308C93 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX114;
115GSE6532B_GSM150928KIU_309C49 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX115;
116GSE6532B_GSM150929KIU_314B55 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX116;
117GSE6532B_GSM150930KIU_316C64 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX117;
118GSE6532B_GSM150931KIU_36C17 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX118;
119GSE6532B_GSM150933KIU_42C67 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX119;
120GSE6532B_GSM150934KIU_43C47 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX120;
121GSE6532B_GSM150935KIU_52A90 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX121;
122GSE6532B_GSM150936KIU_5B97 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX122;
123GSE6532B_GSM150937KIU_65A68 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX123;
124GSE6532B_GSM150938KIU_74A63 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX124;
125GSE6532B_GSM150939KIU_86A40 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX125;
126GSE6532B_GSM150940KIU_87A79 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX126;
127GSE6532B_GSM150941KIU_88A67 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX127;
128GSE6532B_GSM150942KIU_89A64 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX128;
129GSE6532B_GSM150814OXFU_12 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX129;
130GSE6532B_GSM150822OXFU_16 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX130;
131GSE6532B_GSM150840OXFU_37 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX131;
132GSE6532B_GSM150858OXFU_53 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX132;
133GSE6532B_GSM150866OXFU_57 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX133;
134GSE6532B_GSM150872OXFU_88 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX134;
135GSE6532B_GSM150873OXFU_90 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX135;
136GSE6532B_GSM150874OXFU_93 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX136;
137GSE6532B_GSM150806OXFU_104 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX137;
138GSE6532B_GSM150811OXFU_126 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX138;
139GSE6532B_GSM150812OXFU_127 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX139;
140GSE6532B_GSM150817OXFU_138 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX140;
141GSE6532B_GSM150819OXFU_145 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX141;
142GSE6532B_GSM150820OXFU_157 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX142;
143GSE6532B_GSM150823OXFU_181 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX143;
144GSE6532B_GSM150824OXFU_217 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX144;
145GSE6532B_GSM150825OXFU_220 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX145;
146GSE6532B_GSM150826OXFU_223 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX146;
147GSE6532B_GSM150828OXFU_245 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX147;
148GSE6532B_GSM150829OXFU_247 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX148;
149GSE6532B_GSM150830OXFU_254 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX149;
150GSE6532B_GSM150831OXFU_281 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX150;
151GSE6532B_GSM150832OXFU_316 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX151;
152GSE6532B_GSM150833OXFU_320 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX152;
153GSE6532B_GSM150835OXFU_348 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX153;
154GSE6532B_GSM150837OXFU_360 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX154;
155GSE6532B_GSM150838OXFU_366 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX155;
156GSE6532B_GSM150839OXFU_373 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX156;
157GSE6532B_GSM150841OXFU_382 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX157;
158GSE6532B_GSM150842OXFU_397 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX158;
159GSE6532B_GSM150843OXFU_419 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX159;
160GSE6532B_GSM150845OXFU_449 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX160;
161GSE6532B_GSM150847OXFU_476 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX161;
162GSE6532B_GSM150848OXFU_484 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX162;
163GSE6532B_GSM150851OXFU_491 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX163;
164GSE6532B_GSM150852OXFU_513 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX164;
165GSE6532B_GSM150853OXFU_522 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX165;
166GSE6532B_GSM150854OXFU_530 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX166;
167GSE6532B_GSM150855OXFU_531 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX167;
168GSE6532B_GSM150856OXFU_533 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX168;
169GSE6532B_GSM150857OXFU_535 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX169;
170GSE6532B_GSM150859OXFU_543 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX170;
171GSE6532B_GSM150860OXFU_544 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX171;
172GSE6532B_GSM150861OXFU_547 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX172;
173GSE6532B_GSM150862OXFU_549 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX173;
174GSE6532B_GSM150863OXFU_557 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX174;
175GSE6532B_GSM150864OXFU_559 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX175;
176GSE6532B_GSM150865OXFU_573 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX176;
177GSE6532B_GSM150867OXFU_598 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX177;
178GSE6532B_GSM150868OXFU_608 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX178;
179GSE6532B_GSM150869OXFU_662 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX179;
180GSE6532B_GSM150870OXFU_869 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX180;
181GSE6532B_GSM150807OXFU_1065 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX181;
182GSE6532B_GSM150808OXFU_1183 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX182;
183GSE6532B_GSM150809OXFU_1210 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX183;
184GSE6532B_GSM150810OXFU_1248 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX184;
185GSE6532B_GSM150813OXFU_1286 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX185;
186GSE6532B_GSM150815OXFU_1328 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX186;
187GSE6532B_GSM150816OXFU_1373 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX187;
188GSE6532B_GSM150818OXFU_1415 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX188;
189GSE6532B_GSM150821OXFU_1605 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX189;
190GSE6532B_GSM150827OXFU_23 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX190;
191GSE6532B_GSM150834OXFU_337 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX191;
192GSE6532B_GSM150836OXFU_359 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX192;
193GSE6532B_GSM150844OXFU_446 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX193;
194GSE6532B_GSM150846OXFU_471 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX194;
195GSE6532B_GSM150849OXFU_485 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX195;
196GSE6532B_GSM150850OXFU_489 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX196;
197GSE6532B_GSM150871OXFU_885 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX197;
198GSE6532B_GSM150882KIU_125B43 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX198;
199GSE6532B_GSM150900KIU_214C35 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX199;
200GSE6532B_GSM150901KIU_219C42 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX200;
201GSE6532B_GSM150932KIU_38C94 (HG-U133B);Tumor samples from untreated primary breast cancer patients."; CrossRefs: GSE6532A_EX201;
202GSE6532B_GSM151070OXFT_1089 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX202;
203GSE6532B_GSM151071OXFT_1097 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX203;
204GSE6532B_GSM151072OXFT_1103 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX204;
205GSE6532B_GSM151073OXFT_1107 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX205;
206GSE6532B_GSM151074OXFT_1120 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX206;
207GSE6532B_GSM151076OXFT_1127 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX207;
208GSE6532B_GSM151078OXFT_1142 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX208;
209GSE6532B_GSM151079OXFT_114 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX209;
210GSE6532B_GSM151080OXFT_1156 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX210;
211GSE6532B_GSM151081OXFT_1157 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX211;
212GSE6532B_GSM151082OXFT_1167 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX212;
213GSE6532B_GSM151083OXFT_1168 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX213;
214GSE6532B_GSM151084OXFT_116 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX214;
215GSE6532B_GSM151085OXFT_1173 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX215;
216GSE6532B_GSM151086OXFT_1177 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX216;
217GSE6532B_GSM151087OXFT_1181 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX217;
218GSE6532B_GSM151088OXFT_1193 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX218;
219GSE6532B_GSM151089OXFT_1200 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX219;
220GSE6532B_GSM151090OXFT_124 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX220;
221GSE6532B_GSM151091OXFT_1301 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX221;
222GSE6532B_GSM151092OXFT_1320 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX222;
223GSE6532B_GSM151093OXFT_1331 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX223;
224GSE6532B_GSM151095OXFT_1397 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX224;
225GSE6532B_GSM151098OXFT_1525 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX225;
226GSE6532B_GSM151100OXFT_1662 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX226;
227GSE6532B_GSM151101OXFT_1766 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX227;
228GSE6532B_GSM151104OXFT_1800 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX228;
229GSE6532B_GSM151105OXFT_1804 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX229;
230GSE6532B_GSM151106OXFT_1818 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX230;
231GSE6532B_GSM151107OXFT_1821 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX231;
232GSE6532B_GSM151108OXFT_1889 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX232;
233GSE6532B_GSM151110OXFT_192 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX233;
234GSE6532B_GSM151111OXFT_1939 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX234;
235GSE6532B_GSM151112OXFT_1962 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX235;
236GSE6532B_GSM151113OXFT_1981 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX236;
237GSE6532B_GSM151115OXFT_2002 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX237;
238GSE6532B_GSM151116OXFT_2005 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX238;
239GSE6532B_GSM151118OXFT_2057 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX239;
240GSE6532B_GSM151124OXFT_2175 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX240;
241GSE6532B_GSM151129OXFT_2227 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX241;
242GSE6532B_GSM151134OXFT_375 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX242;
243GSE6532B_GSM151135OXFT_380 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX243;
244GSE6532B_GSM151136OXFT_412 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX244;
245GSE6532B_GSM151137OXFT_427 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX245;
246GSE6532B_GSM151138OXFT_429 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX246;
247GSE6532B_GSM151143OXFT_5428 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX247;
248GSE6532B_GSM151144OXFT_550 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX248;
249GSE6532B_GSM151145OXFT_555 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX249;
250GSE6532B_GSM151146OXFT_55 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX250;
251GSE6532B_GSM151147OXFT_588 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX251;
252GSE6532B_GSM151148OXFT_595 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX252;
253GSE6532B_GSM151154OXFT_676 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX253;
254GSE6532B_GSM151156OXFT_697 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX254;
255GSE6532B_GSM151158OXFT_705 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX255;
256GSE6532B_GSM151159OXFT_706 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX256;
257GSE6532B_GSM151160OXFT_711 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX257;
258GSE6532B_GSM151161OXFT_729 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX258;
259GSE6532B_GSM151165OXFT_771 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX259;
260GSE6532B_GSM151166OXFT_779 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX260;
261GSE6532B_GSM151167OXFT_829 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX261;
262GSE6532B_GSM151168OXFT_837 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX262;
263GSE6532B_GSM151169OXFT_848 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX263;
264GSE6532B_GSM151170OXFT_849 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX264;
265GSE6532B_GSM151171OXFT_876 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX265;
266GSE6532B_GSM151172OXFT_887 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX266;
267GSE6532B_GSM151173OXFT_890 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX267;
268GSE6532B_GSM151174OXFT_894 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX268;
269GSE6532B_GSM151175OXFT_913 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX269;
270GSE6532B_GSM151177OXFT_944 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX270;
271GSE6532B_GSM151178KIT_103B41 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX271;
272GSE6532B_GSM151180KIT_112B55 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX272;
273GSE6532B_GSM151182KIT_130B92 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX273;
274GSE6532B_GSM151187KIT_147B19 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX274;
275GSE6532B_GSM151188KIT_148B49 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX275;
276GSE6532B_GSM151189KIT_14B98 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX276;
277GSE6532B_GSM151190KIT_150B81 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX277;
278GSE6532B_GSM151191KIT_154B42 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX278;
279GSE6532B_GSM151192KIT_159B47 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX279;
280GSE6532B_GSM151193KIT_15C94 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX280;
281GSE6532B_GSM151195KIT_165B72 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX281;
282GSE6532B_GSM151196KIT_166B79 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX282;
283GSE6532B_GSM151197KIT_169B79 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX283;
284GSE6532B_GSM151198KIT_170B15 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX284;
285GSE6532B_GSM151199KIT_171B77 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX285;
286GSE6532B_GSM151201KIT_17C40 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX286;
287GSE6532B_GSM151202KIT_183B75 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX287;
288GSE6532B_GSM151203KIT_186B22 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX288;
289GSE6532B_GSM151204KIT_189B83 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX289;
290GSE6532B_GSM151205KIT_191B79 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX290;
291GSE6532B_GSM151206KIT_193B72 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX291;
292GSE6532B_GSM151208KIT_202B44 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX292;
293GSE6532B_GSM151209KIT_203B49 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX293;
294GSE6532B_GSM151211KIT_212C21 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX294;
295GSE6532B_GSM151212KIT_216C61 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX295;
296GSE6532B_GSM151213KIT_225C52 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX296;
297GSE6532B_GSM151214KIT_230C47 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX297;
298GSE6532B_GSM151215KIT_235C20 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX298;
299GSE6532B_GSM151216KIT_238C87 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX299;
300GSE6532B_GSM151217KIT_239C32 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX300;
301GSE6532B_GSM151218KIT_244C89 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX301;
302GSE6532B_GSM151219KIT_245C22 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX302;
303GSE6532B_GSM151221KIT_254C80 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX303;
304GSE6532B_GSM151222KIT_256C45 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX304;
305GSE6532B_GSM151223KIT_271C71 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX305;
306GSE6532B_GSM151224KIT_27C82 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX306;
307GSE6532B_GSM151225KIT_288C57 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX307;
308GSE6532B_GSM151227KIT_291C17 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX308;
309GSE6532B_GSM151228KIT_298C47 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX309;
310GSE6532B_GSM151229KIT_301C66 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX310;
311GSE6532B_GSM151230KIT_307C50 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX311;
312GSE6532B_GSM151233KIT_35C29 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX312;
313GSE6532B_GSM151235KIT_40C57 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX313;
314GSE6532B_GSM151236KIT_41C65 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX314;
315GSE6532B_GSM151239KIT_51A98 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX315;
316GSE6532B_GSM151240KIT_53A06 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX316;
317GSE6532B_GSM151242KIT_56A94 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX317;
318GSE6532B_GSM151243KIT_63A62 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX318;
319GSE6532B_GSM151244KIT_64A59 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX319;
320GSE6532B_GSM151245KIT_67A43 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX320;
321GSE6532B_GSM151248KIT_71A50 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX321;
322GSE6532B_GSM151251KIT_77A50 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX322;
323GSE6532B_GSM151252KIT_79A35 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX323;
324GSE6532B_GSM151253KIT_7B96 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX324;
325GSE6532B_GSM151255KIT_84A44 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX325;
326GSE6532B_GSM151256KIT_85A03 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX326;
327GSE6532B_GSM151258KIT_96A21 (HG-U133B);Tumor samples from tamoxifen treated primary breast cancer patients."; CrossRefs: GSE6532A_EX327;